23,81k Follower • 14 Symbole Watchlist von TREA
Folgen Sie dieser Liste, um Aktien von Unternehmen zu finden und verfolgen, die an der Behandlung von COVID-19 beteiligt sind.
Zusammengestellt von TREA
Watchlist | Änderung heute | Monatlicher Ertrag | Jährlicher Ertrag | Gesamtertrag |
---|---|---|---|---|
Der Kampf gegen COVID19 | -0.31% | - | - | - |
^GSPC | -1.57% | -3.97% | +20.82% | +5314.72% |
Symbol | Firmenname | Letzter Preis | Änderung | % Schwankung | Marktzeit | Volumen | Durchschn. Vol. (3 Monate) | Marktkap. |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 144.59 | -2.23 | -1.52% | 16:00 GMT-4 | 8,72M | 7,64M | 348,43B |
ABBV | AbbVie Inc. | 162.64 | +1.12 | +0.69% | 16:00 GMT-4 | 5,43M | 5,78M | 287,98B |
PFE | Pfizer Inc. | 25.62 | -0.02 | -0.08% | 16:00 GMT-4 | 37,88M | 40,22M | 145,07B |
SNY | Sanofi | 49.23 | +0.14 | +0.29% | 16:00 GMT-4 | 2,86M | 2,10M | 122,90B |
REGN | Regeneron Pharmaceuticals, Inc. | 890.66 | -1.82 | -0.20% | 16:00 GMT-4 | 627,94k | 465,65k | 98,14B |
GSK | GSK plc | 41.44 | -0.17 | -0.41% | 16:00 GMT-4 | 2,98M | 3,43M | 85,35B |
GILD | Gilead Sciences, Inc. | 65.2 | -0.74 | -1.12% | 16:00 GMT-4 | 7,10M | 7,43M | 81,30B |
MRNA | Moderna, Inc. | 110.31 | -1.31 | -1.17% | 16:00 GMT-4 | 3,17M | 3,78M | 42,24B |
TAK | Takeda Pharmaceutical Company Limited | 13.08 | -0.09 | -0.68% | 16:00 GMT-4 | 908,25k | 1,78M | 41,68B |
BNTX | BioNTech SE | 88.82 | +0.87 | +0.99% | 16:00 GMT-4 | 401,44k | 588,05k | 21,40B |
VIR | Vir Biotechnology, Inc. | 8.46 | +0.09 | +1.08% | 16:00 GMT-4 | 1,06M | 1,02M | 1,15B |
NVAX | Novavax, Inc. | 4.33 | +0.04 | +0.93% | 16:00 GMT-4 | 4,18M | 7,08M | 607,95M |
INO | Inovio Pharmaceuticals, Inc. | 11.45 | -0.05 | -0.43% | 16:00 GMT-4 | 181,98k | 468,99k | 296,63M |
Pfizer stock was rising Wednesday after the vaccine maker beat first-quarter earnings expectations and raised its adjusted profit outlook for the year. Pfizer reported first-quarter adjusted earnings of 82 cents a share on revenue of $14.88 billion. “We delivered strong performance in our non-Covid product portfolio in the first quarter of 2024,” Chief Executive Albert Bourla said in a press release.
CVS posts a wide miss on first-quarter earnings, AMD shares fall after the chip maker issues disappointing guidance, and Amazon’s profit is driven by strong growth in cloud computing.
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.